Our website refers to the Global Reporting Initiative (GRI) Standards.The...
Basic Policy for Enterprise Risk Management (ERM) In order to ensu...
Sustainability information We have received independent assurance so a...
The ONO Group’s Health Up Declaration Based on our corporate ph...
We provide training for all employees involved in promotion activities to...
The Ono Pharmaceutical Group's performance may be significantly affected ...
We have two GMP-compliant production sites, namely our Fujiyama Plant (...
Traveling Science Workshop "Kusuri no Himitsu Manabu" Efforts for Canc...
Ensuring Quality and Safety Initiatives for Proper Use of Pharmaceuti...
Environment Global Policy Medium- to Long-term Environmental Vision ...
Handling of the active pharmaceutical ingredient (API) and environmental ...
At Fujiyama Plant, employees periodically clean the area surrou...
Contributing to sustainable social development through business activit...
ONO Pharmaceutical’s Compliance System Initiatives to Strengthen Comp...
Collaboration with business partners is essential to reducing Scope 3...
We consider the collection of safety information regarding pharmaceutical...
We have established an internal system in accordance with the basic views...
We aim for highly transparent management, recognize the importance of ...
We are making efforts to meet unmet medical needs and contribute to medical...
We cooperate with and hold seminars for citizens to raise awareness of ...